Transparency Market Research (TMR) has published a research study on the global organ preservation solutions market, estimating it to register a healthy CAGR of 16.50% over the period from 2013 to 2019 and reach a value of US$0.2 bn by the end of the forecast period. The market report, titled “Organ Preservation Solutions Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019”, further states that the worldwide market for organ preservation solutions had reached US$0.06 bn in 2012.
Get Free Sample Research Report:
According to the market study, the rising incidence of organ failures across the world has triggered the demand for good quality replacement organs, resulting in the exponential growth of the global organ preservation solutions market. The improvement in reimbursement policies is also fueling the demand for organ preservation solutions in the global arena. However, various preoccupied notions, such as organ donation disturbs the sanctity of the deceased body, are limiting the numbers of organ donors, thereby hampering the growth of this market to a certain extent.
The report analyzes the global organ preservation solutions market on two fronts: solutions and techniques. Viaspan, hypothermosol, renograf, perfadex, human bio-system (HBS), lifor, siRNA transplant, and custodiol HTK (histidine-tryptophan-ketoglutarate) are the major organ preservation solutions available in this market.
In 2012, the viaspan and the custodial HTK solutions markets collectively accounted for a share of more than 75% in the global market. Experts anticipate the custodial HTK solution segment to exhibit an impressive CAGR of 17.10% over the forecast period, says the report. Static cold storage (SCS) and hypothermic perfusion preservation (HPP) are the major techniques applied for organ preservation, worldwide. At present, the SCS segment is leading the global market on the basis of techniques. However, the HPP segment is likely to post a robust demand over the next few years.
The research report divides the global organ preservation solutions market across North America, Asia Pacific, Europe, and the Rest of the World. Among these, Europe has acquired the leading position. Analysts project this regional market to report the highest as well as the fastest CAGR of 17.30% over the forecast period, maintaining its dominance in the coming years. Many European nations such as Spain follow the ‘opt out’ policy, according to which, a person, if has not denied his/her organ donation, is considered as an organ donor after his/her death. On account of this, the number of organ donors is increasing significantly, boosting the Europe organ preservation solutions market. In 2009, the total number of deceased organ donors was 9,152, which increased to 9,604 in 2011, notes the study.
The market report says that the global market for organ preservation solutions has become highly competitive in recent times, owing to the increasing number of participants. Some of the major companies operating in this market are 21st Century Medicine, BioTime Inc., BioLife Solutions Inc., Bristol-Myers Squibb, CryoLife Inc., Teva Pharmaceutical Industries Ltd., Claris LifeSciences Ltd., Dr. Franz Köhler Chemie GmbH, XVIVO Perfusion AB, Lifeline Scientific, and ToleroTech Inc.
Full Research Report on Global Organ Preservation Solutions Market: